Incorrect!
The answer is a). A 49% LDL-C reduction. In Study GTC-205, the following LDL-C reductions from baseline were demonstrated at Week 4:^†‡ atorvastatin 10 mg QD -38.5% (p<0.0001); atorvastatin 80 mg QD -56.3% (p<0.0001); LODALIS^® 2.0 g BID* + atorvastatin 10 mg QD -49.1% (p<0.0001). The decrease in LDL-C was greater after treatment with the combination atorvastatin-LODALIS^® than after treatment with atorvastatin 10 mg alone (p=0.007), but not different from atorvastatin 80 mg alone (p=0.070).

* LODALIS® 2.0 g bid is not an authorized dose for use in Canada.
The maximum recommended dose is 3 tablets bid or 6 tablets od.